Abstract |
Carbonic fibrous enterosorbent " Vuglesorb" used as a part of complex anti-diabetic treatment contributes to normalization of metabolism, promotes liquidation of ketoacidosis and principal morbid manifestations. Alongside with this, glycaemia and fructosamine blood level come to the norm. Marked anti-atherogenic effect was also observed. The drug is recommended for the treatment of patients with diabetes mellitus.
|
Authors | P M Bodnar, V Ian'zhon', O M Prystupiuk, N I Lopushenko |
Journal | Likars'ka sprava
(Lik Sprava)
1993 Oct-Dec
Issue 10-12
Pg. 102-4
ISSN: 1019-5297 [Print] Ukraine |
Vernacular Title | Klinichna efektyvnist' enterosorbenta "Vuhlesorb" u khvorykh na tsukrovyÄ diabet. |
PMID | 8030290
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Carbosorb
- Powders
- Tablets
- Carbon
|
Topics |
- Carbon
(administration & dosage)
- Combined Modality Therapy
- Diabetes Mellitus, Type 1
(blood, therapy)
- Diabetes Mellitus, Type 2
(blood, therapy)
- Drug Evaluation
- Enterosorption
(methods)
- Humans
- Powders
- Remission Induction
- Tablets
|